Prenen H - Search Results

1

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate.

Prenen H, Cools J, Mentens N, Folens C, Sciot R, Schöffski P, Van Oosterom A, Marynen P, Debiec-Rychter M. Prenen H, et al. Clin Cancer Res. 2006 Apr 15;12(8):2622-7. doi: 10.1158/1078-0432.CCR-05-2275. Clin Cancer Res. 2006. PMID: 16638875

2

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future.

Geukens T, Brandão M, Laenen A, Collignon J, Van Marcke C, Louviaux I, Demey W, Van Wambeke S, Schrijvers D, Lecomte S, Mebis J, Rutten A, Fontaine C, Lybaert W, Aspeslagh S, Goeminne JC, Van Den Bulck H, Seront E, De Backer L, De Roock W, Ignatiadis M, Prenen H, Van Beckhoven D, Heijlen M, Verheezen J, Rottey S, Punie K, de Azambuja E. Geukens T, et al. Among authors: prenen h. ESMO Open. 2022 Dec;7(6):100610. doi: 10.1016/j.esmoop.2022.100610. Epub 2022 Nov 7. ESMO Open. 2022. PMID: 36356416 Free PMC article.

3

Comprehensive Genomic Profiling and Therapeutic Implications for Patients with Advanced Cancers: The Experience of an Academic Hospital.

Teuwen LA, Roets E, D'Hoore P, Pauwels P, Prenen H. Teuwen LA, et al. Among authors: prenen h. Diagnostics (Basel). 2023 May 3;13(9):1619. doi: 10.3390/diagnostics13091619. Diagnostics (Basel). 2023. PMID: 37175010 Free PMC article.

4

Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study.

Delombaerde D, De Sutter J, Croes L, Vervloet D, Moerman V, Van de Veire N, Willems AM, Wouters K, Peeters M, Prenen H, Vulsteke C. Delombaerde D, et al. Among authors: prenen h. Pharmaceuticals (Basel). 2023 Apr 20;16(4):625. doi: 10.3390/ph16040625. Pharmaceuticals (Basel). 2023. PMID: 37111382 Free PMC article.

5

New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer.

Janssens K, Lambrechts C, Geerinckx B, Op de Beeck K, Van Camp G, Oliveres H, Prenen H, Vandamme T, Peeters M. Janssens K, et al. Among authors: prenen h. Curr Treat Options Oncol. 2023 Aug;24(8):965-987. doi: 10.1007/s11864-023-01095-y. Epub 2023 May 22. Curr Treat Options Oncol. 2023. PMID: 37212934 Review.

6

Differential protein expression profile in gastrointestinal stromal tumors.

Landuyt B, Prenen H, Debiec-Rychter M, Sciot R, de Bruijn EA, van Oosterom AT. Landuyt B, et al. Among authors: prenen h. Amino Acids. 2004 Dec;27(3-4):335-7. doi: 10.1007/s00726-004-0140-2. Epub 2004 Nov 12. Amino Acids. 2004. PMID: 15549490

7

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.

Debiec-Rychter M, Cools J, Dumez H, Sciot R, Stul M, Mentens N, Vranckx H, Wasag B, Prenen H, Roesel J, Hagemeijer A, Van Oosterom A, Marynen P. Debiec-Rychter M, et al. Among authors: prenen h. Gastroenterology. 2005 Feb;128(2):270-9. doi: 10.1053/j.gastro.2004.11.020. Gastroenterology. 2005. PMID: 15685537

8

Sensitive and specific quantification of the anticancer agent ZD1839 (Gefitinib) in plasma by on-column focusing capillary liquid chromatography-tandem mass spectrometry.

Guetens G, Prenen H, De Boeck G, Van Dongen W, Esmans E, Lemière F, van Oosterom AT, Schöffski P, de Bruijn EA. Guetens G, et al. Among authors: prenen h. J Chromatogr A. 2005 Jul 29;1082(1):2-5. doi: 10.1016/j.chroma.2005.04.043. J Chromatogr A. 2005. PMID: 16038188

9

Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review.

Schöffski P, Dumez H, Clement P, Hoeben A, Prenen H, Wolter P, Joniau S, Roskams T, Van Poppel H. Schöffski P, et al. Among authors: prenen h. Ann Oncol. 2006 Aug;17(8):1185-96. doi: 10.1093/annonc/mdj133. Epub 2006 Jan 17. Ann Oncol. 2006. PMID: 16418310 Free article. Review.

10

Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients.

Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, Pauwels P, De Wever I, Vermeesch JR, de Raedt T, De Paepe A, Speleman F, van Oosterom A, Messiaen L, Legius E. Maertens O, et al. Among authors: prenen h. Hum Mol Genet. 2006 Mar 15;15(6):1015-23. doi: 10.1093/hmg/ddl016. Epub 2006 Feb 6. Hum Mol Genet. 2006. PMID: 16461335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters